Komori
General Meetings of Shareholders4528ONO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Shareholder Meeting Materials

Notice was given that the 78th Annual General Meeting of Shareholders will be held and that proposals concerning the appropriation of surplus and the election of 6 directors will be submitted. All director candidates are standing for re-election, including 3 outside directors.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
40
Yen per share (final dividend)
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual, 78th
2026
Jun 18
Date and time(Thursday), 10:00 a.m.28 days from this disclosure to the meeting
Matters for resolution2 items
  1. Disposition of surplus

  2. Election of 6 directors

Shareholder Proposal

No

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
6Nominees
0New
3Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual, 78th
Date and time18 June 2026 (Thursday), 10:00 a.m.
Matters for resolutionProposal No. 1: Disposition of surplus, Proposal 2: Election of 6 directors
Shareholder ProposalNo
Director nominee6, including 0 new and 3 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company considers returning profits to shareholders an important policy and pays dividends in accordance with its progressive dividend policy, taking into account its performance and various indicators. The election of directors is due to the expiration of the terms of office of the 6 current directors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Shareholder Meeting Materials | ONO PHARMACEUTICAL CO.,LTD. (4528) timely disclosure | Komori